PARP1 Inhibitor Combined With Oxaliplatin Efficiently Suppresses Oxaliplatin Resistance in Gastric Cancer-Derived Organoids via Homologous Recombination and the Base Excision Repair Pathway

Overview of attention for article published in Frontiers in Cell and Developmental Biology, August 2021

Altmetric Badge

Mentioned by

twitter: 1 X user

Readers on

mendeley: 12 Mendeley

So far, Altmetric has seen 1 X post from an account with 3,906 followers.

New Research: PARP1 Inhibitor Combined With Oxaliplatin Efficiently Suppresses Oxaliplatin Resistance in Gastric Cancer-Derived Organoids via Homologous Recombination and the Base Excision Repair Pathway: Oxaliplatin (OXA) resistance in the… https://t.co/D

23 Aug 2021

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.